A report of drug reactions with HER2-Positive BC from the Italian pharmacovigilance database, showed serious AEs reports of anti-HER2 therapy mainly involved the following: thrombocytopenia, diarrhea, asthenia, cardiac failure, vomiting, hypersensitivity, ejection fraction decreased and stomatitis [20]. The gene discussed is ERBB2; the disease is heart failure.